ABBOTINDIABSEAbbott India LtdLowNeutral
Announced Wed, 22 Apr · 12:29 IST

Outcome of Board Meeting.

Board & Shareholder Meetings View source PDF

ABBOTINDIA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.2%1-day move
₹25400.00
prior close
₹25495.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.1-0.1+0.2+0.2-0.8+0.0+0.6+0.4+0.0+8.2+9.7+2.6+13.8
Up moveDown movePending
AI summary

Abbott India Limited's Board meeting on April 22, 2026 resulted in multiple leadership changes. Ms. Anisha Motwani completed her second term as Independent Director effective April 24, 2026. Ms. Alison Davies resigned as Director the same day due to other professional commitments. The Board appointed Mr. Neeraj Jain (a Chartered Accountant with 30+ years experience at J&J and HUL) as Additional Independent Director for 3 years from April 25, 2026, and Mr. James Wenner (Vice President, Treasurer at Abbott Laboratories, USA) as Additional Non-Executive Director from April 23, 2026. Both appointments require shareholder approval via postal ballot. Additionally, Mr. Tushar Singh (Plant Director - Goa) is moving to another Abbott affiliate from June 1, 2026, to be succeeded by Mr. Amol Metkar (currently Associate Director - Production at EPD Baddi).

Likely market impact

These changes reflect routine board refreshment and internal talent movement within the Abbott group. The appointments of Mr. Jain (strong finance and M&A background) and Mr. Wenner (Abbott global treasury head) bring relevant expertise to the board. The postal ballot for shareholder approval is a standard procedure.